Intrathecal clonidine and severe hypotension after cardiopulmonary bypass
- PMID: 14570631
- DOI: 10.1213/01.ANE.0000083526.08033.20
Intrathecal clonidine and severe hypotension after cardiopulmonary bypass
Abstract
The use of intrathecal clonidine as an adjunct for the management of chronic pain, intra- and postoperative analgesia is gaining an increase in popularity. However, antinociceptive doses of intrathecal clonidine may produce pronounced hemodynamic side effects, including hypotension and bradycardia. In this report, we present a case of severe hypotension after cardiopulmonary bypass in a patient with intrathecal clonidine infusion. We postulate that the intrathecally administered alpha 2-agonist clonidine reduced our patient's ability to tolerate the hemodynamic lability that is present during the separation from cardiopulmonary bypass by potentially inhibiting sympathetic nervous system activity, renin-angiotensin system, or vasopressin release. The authors report a case of severe hypotension after cardiopulmonary bypass in a patient receiving intrathecal clonidine infusion for chronic neuropathic pain.
References
-
- Walker SM, Goudas LC, Cousins MJ, Carr DB. Combination spinal analgesic chemotherapy: a systemic review. Anesth Analg 2002; 95: 674–715.
-
- Eisenach JC, De Kock M, Klimscha W. Alpha sub 2-adrenergic agonists for regional anesthesia: a clinical review of clonidine (1984–1985). Anesthesiology 1996; 85: 655–74.
-
- Uhle EI, Becker R, Gatscher S, Bertalanffy H. Continuous intrathecal clonidine administration for the treatment of neuropathic pain. Stereotact Funct Neurosurg 2000; 75: 167–75.
-
- Rainov NG, Heidecke V, Burkert W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 2001; 22: 862–71.
-
- Kambibayashi T, Maze M. Clinical uses of α2-adrenergic agonists. Anesthesiology 2000; 93: 1345–9.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
